Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Company dna ch kilger anwaltspartnerschaft mbb
no operation time available
1 office
active in Legal Services

We have observed 13 EP applications Siegfried Schreiner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 28, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12007504

Method for the production of multispecific antibodies

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12007506

Trispecific antibodies against human EGFR, HER2 and HER3

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12007505

Bispecific antibodies against human EGFR, HER2, and HER3

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13000570

Method for the selection of antibodies against BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13000571

Bispecific antibodies against CD3epsilon and BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13001840

Bispecific antibodies against CD3e and ROR1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/40
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14702616

METHOD FOR THE SELECTION OF ANTIBODIES AGAINST BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14705304

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61P 31/00, C07K 16/28
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP14179705

Bispecific antibodies against CD3epsilon and BCMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION PUBLISHED
EP14715967

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/40
Agent:
Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP15179545

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
David James Miller, Mathys & Squire LLP
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
PATENT GRANTED
EP14194151

Bispecific antibodies against CD3epsilon and BCMA

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/46
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION REFUSED
EP14196168

Bispecific antibodies against CD3epsilon and BCMA for use in the treatment of diseases

IPC classification:
A61P 35/00, C07K 16/28, G01N 33/574
Agent:
Siegfried Schreiner, CH Kilger Anwaltspartnerschaft mbB
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature